Daron Street, MD
Basic profileDaron Street is an Oncology physician affiliated with Oklahoma Cancer Specialists and Research Institute. OpenAlex indexes 15 publications with 481 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
51 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- INTUITIVE SURGICAL, INC.Program year20251 payment$4,000
- E.R. Squibb & Sons, L.L.C.Program year20251 payment$2,275
- BeOne Medicines USA, Inc.Program year20254 payments$305
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.9%Platinum-based Drug16.2%Oxaliplatin98%Carboplatin2%Part B, office-administered≥18 patientsPD-1 inhibitor14.7%Pembrolizumab100%Part B, office-administered≥17 patients+ 3 more classes in this area
Blood & clotting
35.1%Iron, parenteral preparations35.1%Ferric carboxymaltose100%Part B, office-administered≥21 patientsFactor Xa inhibitor0%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
19%Serotonin-3 Receptor Antagonist10%Granisetron91%Palonosetron hcl7%Ondansetron hydrochloride2%Ondansetron Hcl0%Part D + Part B≥34 patientsSubstance P/Neurokinin-1 Receptor Antagonist9%Aprepitant100%Part B, office-administered≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Katherine Moxley, MD
Oklahoma Cancer Specialists and Research Institute
Janelle Pavlis, MD
Oklahoma Cancer Specialists and Research Institute
Paul Zito, MBBS
Oklahoma Cancer Specialists and Research Institute
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”